PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn Medicine at the 2023 ASCO Annual Meeting

2023-05-25
(Press-News.org) CHICAGO –  Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in clinical cancer research at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from June 2-6 in Chicago, Illinois. Follow us on Twitter @PennMDForum and @PennCancer for updates.

Expert Interviews

Experts from the Perelman School of Medicine are available to comment on a wide range of topics in cancer science and medicine during the meeting on site and by video call, telephone, or email. To arrange interviews, please contact Meagan Raeke at Meagan.Raeke@pennmedicine.upenn.edu or 267-693-6224.

Incoming ASCO Leaders from Penn Medicine

ASCO President-Elect Lynn M. Schuchter, MD, FASCO, the Madlyn and Leonard Abramson Professor of Clinical Oncology and director of the Tara Miller Melanoma Center, will begin her term as ASCO President for 2023-2024 at the end of the Annual Meeting. Learn more about her election to the top professional society for cancer care.

In addition, Angela DeMichele, MD, MSCE, the Jill & Alan Miller Endowed Chair in Breast Cancer Excellence, will serve as chair of the Scientific Program Committee, and Charu Aggarwal, MD, MPH, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence in Hematology-Oncology, will serve as chair of the Communications Committee for the 2024 ASCO Annual Meeting.

News Releases

Two Penn Medicine Abramson Cancer Center Faculty Members Receive Top ASCO Awards

Check back for additional news as embargos lift during the meeting.

Key Presentations

Penn Medicine researchers will present results from clinical trials for recurrent glioblastoma and metastatic HR+/HER2- breast cancer. Experts will also present studies focused on serious illness conversations for patients with cancer, the effect of Medicaid expansion on clinical trial enrollment, and infertility among female oncologists. Key presentations include:

Central Nervous System Tumors

Phase II study of immunotherapy with fractionated stereotactic radiotherapy for recurrent glioblastoma (Abstract 2004): In a single-center, multi-arm study involving patients with recurrent glioblastoma, Stephen Bagley, MD, MSCE, an assistant professor of Hematology-Oncology and Neurosurgery, and colleagues, evaluated the immunotherapy drugs retifanlimab (an anti-PD1 agent) and INCAGN01876 (a GITR agonist) in combination with fractionated stereotactic radiotherapy, which was administered as an immunostimulatory strategy. In the cohort of patients who received the immunotherapy drug combination as neoadjuvant therapy prior to surgery, patients who also received neoadjuvant radiotherapy (Cohort B1) experienced a clear overall survival benefit compared to patients who received only neoadjuvant immunotherapy (Cohort B2). Stronger and more sustained inflammatory and cellular immune responses in the peripheral blood were also seen in Cohort B1, supporting preclinical evidence that fractionated stereotactic radiotherapy may help stimulate an anti-tumor immune response. Efficacy of the treatment regimen was not observed in Cohort B2 or the other group of patients whose treatment plans did not include surgery (Cohort A). Bagley will present the findings in an oral abstract session on Friday, June 2, at 2:45 p.m. CT in S100a. Breast Cancer

BRACELET-1 (PrE0113), a Phase II study of oncolytic reovirus for metastatic HR+/HER2- breast cancer (Abstract 1012): This multicenter clinical trial enrolled 48 patients with HR+/HER2- metastatic breast cancer who were randomized to receive either chemotherapy alone (Cohort 1), chemotherapy in combination with pelareorep, an oncolytic reovirus engineered to attack cancer cells (Cohort 2), or both treatments with the addition of the immunotherapy avelumab (Cohort 3). As the trial co-PI and Penn Medicine site PI Amy Clark, MD, an assistant professor of Hematology-Oncology, and colleagues, found, the early data indicates chemotherapy plus pelareorep has a higher response rate and 6-month progression-free survival compared to chemotherapy alone, and pelareorep increased T-cell responses in blood samples. One third of patients discontinued either pelareorep or avelumab due to adverse side effects from treatment. Clark will present the results during The Dr. Bernard Fisher Memorial Annual Clinical Science Symposium on Saturday, June 3, at 1:15 p.m. CT in S406. Equity in Oncology

Survey on infertility and elective fertility preservation in female oncologists and trainees (Abstract 11001): Emily MacDuffie, MD, a Radiation Oncology resident, and colleagues, designed a survey to learn more about attitudes toward family planning and use of assisted reproductive technology among self-identified United States female oncologists of all career levels. Medical training often coincides with peak fertility years, and female physicians are known to have higher rates of infertility than the general population. Of 1,005 female oncologists surveyed, one-third (32%) reported experiencing infertility. Among those who experienced infertility, 39% reported out-of-pockets costs of $10,000 or more for assisted reproductive technology. About three-quarters of female attending physicians (76%) and trainees (72%) who were interested in future fertility preservation were unsure of the feasibility to do so. MacDuffie will present the results in a clinical science symposium session on Saturday, June 3 at 4:30 p.m. CT in S100a.  Health Services Research, Quality Improvement, Care Delivery and Regulatory Policy

End-of-life spending analysis from serious illness communication nudge study (Abstract 6515): This secondary analysis follows the results of randomized clinical trial, published in JAMA Oncology in January, that found machine learning-triggered nudges to prompt serious illness communication among patients with cancer improved end-of-life care. In this follow-up, lead author Ravi B. Parikh, MD, an assistant professor of Medical Ethics and Health Policy and Medicine, and colleagues, found that the intervention also resulted in lower spending on care in the last 180 days of life, driven primarily by lower spending on chemotherapy, outpatient care, and other therapies. Parikh will present the results during a poster discussion session on Saturday, June 3 at 4:30 p.m. CT in E350.
  Patient- and clinician-directed strategies to improve serious illness communication (Abstract 1514): Following the above nudge model to prompt serious illness conversations, this randomized clinical trial added another layer: a patient-facing message sent electronically before a clinic visit, with a three-question survey designed to prime patients for a serious illness conversation with their oncology team. In a study that enrolled 4,450 patients with cancer, Samuel Takvorian, MD, MS, an assistant professor of Hematology-Oncology, and colleagues, found that when both patients and physicians received a nudge, serious illness conversations were more likely to take place, compared to a control group or only one party receiving the nudge. Takvorian will present the results during a poster discussion session on Monday, June 5 at 4:30 p.m. CT in S102.
  Medicaid expansion and accrual of Black and Hispanic patients to cancer clinical trials (Abstract 1510): Using anonymous data from 75,700 participants across 1,409 clinical trials and 351 sites, Takvorian and colleagues compared clinical trial demographics in states that did and did not expand Medicaid eligibility under the Affordable Care Act to determine if the expansion increased the percentage of Black and Hispanic patients enrolled in oncology clinical trials. Although Medicaid expansion alone did not make a statistically significant impact, in states that mandated Medicaid cover the routine costs of trial participation, Black and/or Hispanic participant enrollment significantly increased. Takvorian will present the results during a poster discussion session on Monday, June 5 at 4:30 p.m. CT in S102.

###

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.

The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.

END



ELSE PRESS RELEASES FROM THIS DATE:

Internal job candidates have a leg up

2023-05-25
AUSTIN, Texas – Internal job candidates have an advantage over external candidates, because they tend to work harder shortly before a hiring decision, according to new research from The University of Texas at Austin. This is true even when an internal candidate’s skills are inferior. Eric Chan, assistant professor of accounting at the McCombs School of Business, found that when a new job is on the line, employees will exert more effort to increase their chances of promotion — especially right before the decision. And managers are more likely ...

C. difficile, emerging pathogens, genomics, and antimicrobial resistance

C. difficile, emerging pathogens, genomics, and antimicrobial resistance
2023-05-25
A new study published in the peer-reviewed OMICS: A Journal of Integrative Biology identified genes for virulence and antimicrobial resistance in two bacteria that co-occur with C. difficile, suggesting these pathogens as emerging potential threats in planetary health. Click here to read the article now. Thokur Sreepathy Murali, PhD, Ankit Singh Tanwar, Padival Shruptha and colleagues from Manipal Academy of Higher Education, India, and co-author Angela Brand, MD, PhD, MPH from Maastricht University, The Netherlands, performed comparative genome analyses of three Clostridia species, ...

Groundbreaking images of root chemicals offer new insights on plant growth

Groundbreaking images of root chemicals offer new insights on plant growth
2023-05-25
On a sunny springtime stroll through a park, it’s easy to ignore the parts of plants that are hidden from view. Plant biologists see things differently. They look below the surface where plant roots are organized in elaborate systems that are critical to the organism’s development. Intricately organized tree root systems, for example, can span as far underground as the tree grows high above the soil. Applying an advanced imaging technology to plant roots, researchers at the University of California San Diego and Stanford University ...

LJI-led team wins top Nucleate honors for virus vaccine development proposal

2023-05-25
LA JOLLA, CA—A San Diego team, led by scientists at La Jolla Institute for Immunology (LJI), has won the top prizes in the Nucleate Activator competition. Out of 1,000 initial competitors, the LJI team advanced to the final four teams and swept all the prizes they entered for. Their winning research proposal outlines how scientists could stop dengue virus and Zika virus by developing sophisticated vaccines that activate both B cells and T cells. Nucleate is a student-led, non-profit organization dedicated to empowering early-stage, ...

Hydrogen battery: Storing hydrogen in coal may help power clean energy economy

Hydrogen battery: Storing hydrogen in coal may help power clean energy economy
2023-05-25
UNIVERSITY PARK, Pa. — The quest to develop hydrogen as a clean energy source that could curb our dependence on fossil fuels may lead to an unexpected place — coal. A team of Penn State scientists found that coal may represent a potential way to store hydrogen gas, much like batteries store energy for future use, addressing a major hurdle in developing a clean energy supply chain. “We found that coal can be this geological hydrogen battery,” said Shimin Liu, associate professor of energy and mineral engineering at Penn State. “You could inject and store the hydrogen energy and have it there when you need to use it.” Hydrogen ...

Artificial muscle fibers could serve as cell scaffolds

2023-05-25
In two new studies, North Carolina State University researchers designed and tested a series of textile fibers that can change shape and generate force like a muscle. In the first study, the researchers focused on the materials’ influence on artificial muscles’ strength and contraction length. The findings could help researchers tailor the fibers for different applications. In the second, proof-of-concept study, the researchers tested their fibers as scaffolds for live cells. Their findings suggest the fibers – known as “fiber robots” ...

Argonne hosts demo day for Lab-Embedded Entrepreneurship Program

2023-05-25
Twenty startups will present their technologies for a clean energy future at this year’s Lab-Embedded Entrepreneur Program (LEEP) Demo Day, June 7, in Chicago. LEEP connects entrepreneurs with resources and innovation ecosystems at U.S. Department of Energy (DOE) national labs.  In addition to demos from companies currently participating in LEEP, the event at the Sheraton Grand Chicago Riverwalk will also feature a panel discussion where program graduates share insights and advice about successful entrepreneurship. The technologies on display span renewable energy, materials for clean energy and water, batteries, ...

Helping virtual reality reflect social realities

Helping virtual reality reflect social realities
2023-05-25
Research on virtual reality is expanding as the technology grows, but too much of that research is being conducted with participants who don’t reflect the general population. The Virtual Experience Research Accelerator (VERA), a $5 million National Science Foundation-funded project, is creating a system to provide researchers with access to large, reliable, diverse groups of participants for an array of research projects on and using VR. “A lot of research in this area suffers from using participant samples ...

New method tracking changes in blood vessels could advance brain disease detection

2023-05-25
PROVIDENCE, R.I. [Brown University] — While age-related brain disorders like Alzheimer’s disease often develop slowly across an individual’s lifetime, they usually aren’t detected until symptoms have already started. With that in mind, teams of biomedical researchers led by Brown University scientists have been exploring for years whether devastating neurodegenerative diseases could be caught decades earlier — perhaps through something as simple as a routine eye exam instead of a battery of diagnostic tests. In a new study, one of the Brown-led ...

New framework for super-resolution ultrasound

New framework for super-resolution ultrasound
2023-05-25
Researchers at the Beckman Institute for Advanced Science and Technology used deep learning to develop a new framework for super-resolution ultrasound. Traditional super-resolution ultrasound techniques use microbubbles: tiny spheres of gas encased in a protein or lipid shell. Microbubbles are considered to be a contrast agent, which means they can be injected into a blood vessel to increase the clarity of an ultrasound image. Conventional ultrasound has been commonplace for over 50 years. The development of super-resolution technology in the last decade has introduced new challenges. Super-resolution ultrasound provides a much clearer picture than the traditional method. ...

LAST 30 PRESS RELEASES:

Altering cancer treatment dosing could reduce climate impact, study finds

The secret sex life of coral revealed

New deep learning model is ‘game changer’ for measuring embryo development

Smarter foragers do not forage smarter

A unified account of Darwinism’s varieties

Marketers can manage 'feature creep'

Intermittent fasting shows promise in improving gut health, weight management

Scientists identify gene that could lead to resilient ‘pixie’ corn

Utilizing medical assistants to manage patient portal messages shown to support practice and physician efficiency

Study shows clinic continuity associated with reduced hospital and emergency visits

Recognizing the range of experiences among individuals of Latino, Hispanic, and/or Spanish origin is an essential step toward health equity

study reveals decline in reported medicare outpatient procedures by family physicians amid an aging population

COVID-19 pandemic leads to drop in breast cancer screenings, especially among older and racial minority women

Translating the Surgeon General’s framework on social isolation and loneliness to actionable steps in primary care

Point/counterpoint: Is prediabetes overdiagnosed?

Primary care clinics can help low-income families receive nutritional support benefits

The wall of evidence for continuity of care

Parents of children with serious illness from Somali, Hmong, and Latin American communities desire better communication and support in pediatric health care

Primary care can improve hygienic practices while reducing waste

HKUST researchers enhance performance of eco-friendly cooling applications by developing sustainable strategy to manipulate interfacial heat transfer

Variations in medical assistant to primary care clinician staffing ratios may reflect differences in practice ownership and organizational culture

Better disciplinary structures in schools can help reduce hate speech directed against Asian American students

Bringing back an ancient bird

Wistar research identifies mechanisms for selective multiple sclerosis treatment strategy

Fatherhood’s hidden heart health toll

The importance of integrated therapies on cancer: Silibinin, an old and new molecule

Texas A&M-led team creates first global map of seafloor biodiversity activity

Light therapy increases brain connectivity following injury

Power imbalance in health care reveals impact of race and role on team dynamics and DEI efforts

NRG Oncology appoints new vice-chairs for their patient advocate committee

[Press-News.org] Penn Medicine at the 2023 ASCO Annual Meeting